The document “Results of Annual Meeting” was lodged with ASX on 5 May 2021.
Please click to review the full announcement on ASX.
MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to report that it
SINGAPORE, and San Diego, California – Prestige Biopharma, a biopharmaceutical company specializing in innovative antibody therapies, with a strong dedication to tackling pancreatic cancer, and Imagion
We’re on a mission to make cancer more detectable.